Production of a retroviral P15E-related chemotaxis inhibitor by IL-1-treated endothelial cells. A possible negative feedback in the regulation of the vascular response to monokines.
The effects of IL-1 on vascular endothelium result in a complex set of alterations which are potentially disruptive of vessel wall and underlying tissue integrity. The present study was aimed at investigating possible regulation of such potentially destructive responses elicited by IL-1 on endothelial cells. Culture supernatants of IL-1-treated human umbilical vein endothelial cells (HEC) were depleted of retroviral p15E-related Ag with immobilized anti-p15E mAb. The monocyte chemotactic and polarizing activity of supernatants of IL-1-treated HEC (presumably related to colony-stimulating factors being released by HEC) was markedly augmented by absorption on immobilized anti-p15E antibodies. Irrelevant IgG had no effect and anti-p15E antibodies did not affect the chemotactic activity of supernatants from unstimulated HEC. The material eluted from Sepharose-bound anti-p15E antibodies was devoid of chemotactic and polarizing activity and suppressed the polarization and migration of monocytes in response to chemoattractants. The alpha and beta molecular species of IL-1 were equally effective in inducing the production of p15E-related inhibitor. The production of a p15E-related inhibitor of chemotaxis induced by IL-1 in HEC may represent a negative signal in the regulation of the potentially destructive responses to pro-inflammatory cytokines.
Wang
J M
JM
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Chen
Z G
ZG
Cianciolo
G J
GJ
Snyderman
R
R
Breviario
F
F
Dejana
E
E
Mantovani
A
A
D000626:Aminopeptidases; D000818:Animals; D002465:Cell Movement / Q000187:drug effects; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D002630:Chemotactic Factors / Q000032:analysis / Q000037:antagonists & inhibitors* / Q000096:biosynthesis / Q000502:physiology; D002634:Chemotaxis, Leukocyte / Q000187:drug effects*; D004730:Endothelium, Vascular / Q000378:metabolism* / Q000502:physiology; D015683:Gene Products, gag; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology*; D009052:Leukemia Virus, Murine; D051379:Mice; D009000:Monocytes / Q000502:physiology; D011994:Recombinant Proteins / Q000494:pharmacology; D012191:Retroviridae Proteins / Q000502:physiology*; D015682:Retroviridae Proteins, Oncogenic
D002630:Chemotactic Factors; D015683:Gene Products, gag; D007375:Interleukin-1; D011994:Recombinant Proteins; D012191:Retroviridae Proteins; D015682:Retroviridae Proteins, Oncogenic; C010073:chemotactic factor inactivator; C039467:virus structural protein p15; D000626:Aminopeptidases